Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118198633 | 11819863 | 3 | F | 201402 | 20160711 | 20151210 | 20160725 | EXP | US-JNJFOC-20151111245 | JANSSEN | 13.57 | YR | C | M | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118198633 | 11819863 | 1 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | IN VARYING DOSES OF 0.50MG TO 1.00MG | N | 20272 | UNSPECIFIED | ||||||||
| 118198633 | 11819863 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | U | 20272 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118198633 | 11819863 | 1 | Bipolar disorder |
| 118198633 | 11819863 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118198633 | 11819863 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118198633 | 11819863 | Gynaecomastia | |
| 118198633 | 11819863 | Obesity | |
| 118198633 | 11819863 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118198633 | 11819863 | 1 | 2012 | 2015 | 0 |